Intel stock extends gains after report of possible U.S. government stake
GUERNSEY - RTW Biotech Opportunities Ltd has announced that its Annual General Meeting (AGM) is set to take place on June 9, 2025, at 2pm BST in St Peter Port, Guernsey. This gathering will allow shareholders to discuss the company’s performance and future plans.
The notification for the AGM was formally issued to all shareholders on May 15, 2025. In line with modern practices and environmental considerations, the company has opted not to send hard copy proxy forms through the post. Instead, shareholders are encouraged to cast their proxy votes electronically via the Investor Centre app or through the website at https://uk.investorcentre.mpms.mufg.com/.
The AGM’s agenda and related materials, including the Annual Report and Audited Financial Statements for the year ended December 31, 2024, are available for review on the company’s website. These documents provide transparency and detailed insights into the company’s financial health and strategic direction.
Shareholders intending to vote by proxy should ensure their votes reach the company’s registrar no later than 2pm BST on June 5, 2025. Those who hold shares through a broker or nominee will need to communicate their voting preferences to the respective parties, as they cannot directly vote through the provided online platform.
RTW Biotech Opportunities Ltd has also set a deadline for shareholder queries regarding the AGM’s business. Questions must be submitted by 2pm BST on June 5, 2025, to the designated email address, ensuring that shareholders’ concerns can be addressed adequately.
This announcement is based on a press release statement and serves to inform shareholders and the public about the upcoming AGM, highlighting the company’s adherence to good corporate governance practices.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.